NewsFeed
October, 2026
October 2026
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Roger Yerramsetti: The 1st Baby Born from an Egg Fertilised with MicroICSI
Oct 4, 2026, 15:31

Roger Yerramsetti: The 1st Baby Born from an Egg Fertilised with MicroICSI

Roger Yerramsetti, Chief Executive Officer of Fertilis, shared a post on LinkedIn by Virtus Health, adding:

“Five unsuccessful IVF cycles.

Then she joined our trial.

Conventional ICSI gave no usable embryo – microICSI gave three.

One of those embryos led to a pregnancy, and recently, a healthy baby girl.

It’s the first live birth in our clinical trial in Australia, and the first baby born from an egg fertilised with microICSI.

MicroICSI is a 3D-printed device developed by Fertilis that holds the egg during ICSI without suction.

The study is ongoing, and this is the outcome we hoped to see for this patient.

My thanks to Virtus Health, the IVF Australia and Melbourne IVF teams, Fertilis co-founder Prof. David Gardner, and most of all the patient who didn’t give up.”

Quoting Virtus Health’s post:

“Celebrating the Melbourne Scientists helping shape the future of IVF. 

Australian scientists at Melbourne IVF have achieved the first pregnancies using a pioneering 3D-printed IVF device, marking an important early milestone for a world-first Australian innovation.

Known as microICSI, this tiny 3D-printed device – no bigger than the width of a human hair – has been designed to modernise one of the most widely used IVF procedures for severe male infertility.

Using ultra-high-resolution 3D printing, the device creates tiny ‘egg cups’ that gently support each egg during ICSI, when a single sperm is injected into the egg, reducing the need for suction and manual movement during one of the most delicate steps in the ICSI process.

The current clinical study remains ongoing and has resulted in six pregnancies from embryos created using the new microICSI device, with pregnancy outcomes to date comparable with conventional ICSI.

Prof. David Gardner, Group Director of ART, Scientific Research and Innovation at Virtus Health, will present the findings at ESHRE 2026 in London this week.

Swipe through to learn more about the Australian-led innovation and what the early findings could mean for future patients.”

Roger Yerramsatti

Stay updated on all scientific advances in the field of fertility with Fertility News.